Experience

AllRock Bio Closes $50 Million Series A

September 16, 2025

Cooley advised AllRock Bio, a clinical-stage biotechnology company focused on advancing therapies for cardiopulmonary and fibrotic diseases, on its $50 million Series A financing to advance AllRock’s lead molecule, ROC-101, a first-in-class, oral pan-rho-associated protein kinase inhibitor to treat pulmonary arterial hypertension and pulmonary hypertension with interstitial lung disease.

Read more

Related contacts

Ryan Sansom
Partner, Boston
Barry Kuang
Associate, Boston
Danbi Kim
Associate, Boston
Christophe Beauduin
Partner, New York
Megan Boss
Senior Paralegal , Boston
Stephanie Gentile
Partner, New York

Related Practices & Industries

LB Pharmaceuticals Announces $285 Million Upsized IPO

September 12, 2025

Cooley advised LB Pharmaceuticals, a clinical-stage biopharmaceutical company developing novel therapies for the treatment of neuropsychiatric diseases including schizophrenia, on its $285 million upsized initial public offering (IPO).

Read more

Related contacts

Brandon W. Fenn
Partner, New York
Div Gupta
Partner, New York
Marc Recht
Partner, Boston
Minkyu Park
Special Counsel, New York
Denny Xu
Associate, Boston
Danbi Kim
Associate, Boston
Ariane A. Andrade
Partner, Chicago
Nathaniel Hearn Jr.
Associate, Chicago
Karun Ahuja
Special Counsel, Chicago
Brandon Lefebvre
Quantitative Analyst, Boston
Stephanie Gentile
Partner, New York
Austin Holt
Partner, Santa Monica
Eileen Marshall
Partner, Washington, DC
Phil Mitchell
Partner, New York
Gerard O'Shea
Partner, New York
David Peinsipp
Partner, San Francisco
Ryan Vann
Partner, Chicago
Francis Wheeler
Senior Counsel, Colorado
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Sharon Connaughton
Special Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Jessica Koffel
Special Counsel, Brussels
Rebecca Ross
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Chelsea Braun
Associate, Boston
Cara Buchicchio
Associate, New York
David Dalton
Associate, Santa Monica
Vince Flynn
Associate, San Diego
Virat Gupta
Associate, Washington, DC
Wyatt Kernell
Associate, Colorado
Allison Kutner
Associate, New York
Brenna McGuire
Associate, Washington, DC
Sarah Miller
Associate, New York
Jayne M. Munger
Associate, New York
Miles Patton
Associate, New York
Alla Kagan
Paralegal Specialist, San Diego
Cathy Rude
Paralegal Specialist, Boston
Jake Ironfield
Transactional Quantitative Analyst, New York
Brian Mitchell
Transactional Quantitative Analyst, San Diego

Related Practices & Industries

Premier Partners Closes $15 Million Investment in Celltrio

June 17, 2025

Cooley advised Premier Partners on its $15 million investment in Celltrio, a pioneering life sciences company delivering advanced automation solutions for cell culturing and cell and gene therapy. Premier Partners is a growth equity investment firm managing $2.9 billion in assets, focusing on rapidly growing sectors, particularly within the healthcare industry. Partner Sale Kwon led the Cooley team.

Related contacts

Sale Kwon
Partner, Palo Alto
Daniel Y. Lee
Associate, Palo Alto
Celine Koh
Associate, Palo Alto
Danbi Kim
Associate, Boston

Related Practices & Industries

L&F’s Strategic Investment in Mitra Chem to Advance US Battery Production

March 21, 2025

Cooley advised L&F Co., a leading South Korean electric vehicle (EV) battery materials supplier, on its $10 million strategic investment in US-based lithium-ion battery startup Mitra Chem. Partner Sale Kwon led the Cooley team that provided legal advice across due diligence, investment structuring and regulatory compliance. The investment supports L&F’s US expansion and plans for joint lithium iron phosphate (LFP) cathode material production by 2027.

Related contacts

Sale Kwon
Partner, Palo Alto
Daniel Y. Lee
Associate, Palo Alto
Danbi Kim
Associate, Boston

Related Practices & Industries

Battery Ventures-Backed PageUp To Be Acquired by EQT Partners

October 31, 2024

Cooley advised Battery Ventures, a global, technology-focused investment firm, and PageUp Group, a human resources and talent software company that had been majority owned by Battery, on the sale of PageUp to EQT Group.

Read more

Related contacts

Alfred Browne
Partner, Boston
Heather Harrington
Special Counsel, Boston
David Silverman
Partner, New York
Megan Browdie
Partner, Washington, DC
Adam Fleisher
Partner, Washington, DC
Todd Gluth
Partner, San Diego
Blake Martell
Of counsel, San Francisco
Aaron Pomeroy
Partner, Colorado
Thomas Connors
Partner, Boston
Christopher Kimball
Partner, Washington, DC
William Corcoran
Of Counsel, Boston
Rebecca Ross
Special Counsel, Washington, DC
Stella Sarma
Partner, Brussels
Ryan Montgomery
Partner, Boston
Karun Ahuja
Special Counsel, Chicago
Jasmine A. Banks
Associate, Washington, DC
Tessa W Bell
Associate, Colorado
Patrick O. Johnson
Associate, Boston
Nick Kenyon
Associate, Boston
Danbi Kim
Associate, Boston
Xueqing Li
Associate, San Francisco
Katrina Morris
Associate, Boston
Yi Jia Ng
Special Counsel, Singapore
Amanda Pacheco
Associate, Palo Alto
Erica Pedersen
Associate, Boston
Sri Ravipati
Associate, Boston
Mara Rosario
Associate, Boston
Lukas Roth
Associate
Sydney Sachs
Associate, Boston
Matthew S. Scarano
Associate, San Diego
Mo Swart
Associate, London
Rubin Waranch
Associate, Colorado
Agis Zografos
Associate, London
Megan Boss
Senior Paralegal , Boston

Related Practices & Industries

Admissions and credentials

Massachusetts

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.